Alcaftadine Patent Expiration
Alcaftadine is Used for temporarily relieving itchy eyes caused by allergens such as pollen, ragweed, grass, animal hair, and dander. It was first introduced by Abbvie Inc
Alcaftadine Patents
Given below is the list of patents protecting Alcaftadine, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Lastacaft | US8664215 | Ocular allergy treatments with alcaftadine | Dec 23, 2027 | Abbvie |
| Lastacaft | US10617695 | Ophthalmic compositions containing alcaftadine | Mar 19, 2027 | Abbvie |
| Lastacaft | US5468743 | Imidazo[2,1-b]benzazepine derivatives, compositions and method of use |
Nov 21, 2013
(Expired) | Abbvie |
Alcaftadine's Family Patents
Explore Our Curated Drug Screens
Alcaftadine Generic API Manufacturers
Several generic applications have been filed for Alcaftadine. The first generic version for Alcaftadine was by Eugia Pharma Specialities Ltd and was approved on Jun 23, 2023. And the latest generic version is by Alembic Pharmaceuticals Ltd and was approved on Oct 2, 2024.
Given below is the list of companies who have filed for Alcaftadine generic, along with the locations of their manufacturing plants worldwide.
1. ALEMBIC
Alembic Pharmaceuticals Ltd has filed for 1 generic for Alcaftadine. Given below are the details of the strengths of this generic introduced by Alembic.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.25% | solution/drops | Over the counter | OPHTHALMIC | N/A | Oct 2, 2024 |
Manufacturing Plant Locations New
Alembic's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Alembic as present at those locations.
| Country | City | Firm Name | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| India |
| |||||||||||||||
2. EUGIA PHARMA
Eugia Pharma Specialities Ltd has filed for 1 generic for Alcaftadine. Given below are the details of the strengths of this generic introduced by Eugia Pharma.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.25% | solution/drops | Discontinued | OPHTHALMIC | N/A | Jun 23, 2023 |
Manufacturing Plant Locations New
Eugia Pharma's manufacturing plants are situated in 1 country - India. Given below are the details of these plant locations as well as the firm names of Eugia Pharma as present at those locations.
| Country | City | Firm Name | ||||||
|---|---|---|---|---|---|---|---|---|
| India |
| |||||||
3. GLAND PHARMA LTD
Gland Pharma Ltd has filed for 1 generic for Alcaftadine. Given below are the details of the strengths of this generic introduced by Gland Pharma Ltd.
| Strength | Dosage Form | Availability | Application Pathway | TE code | Launch Date |
|---|---|---|---|---|---|
| 0.25% | solution/drops | Over the counter | OPHTHALMIC | N/A | Mar 1, 2024 |